P
2.50
-0.06 (-2.34%)
| Penutupan Terdahulu | 2.56 |
| Buka | 2.57 |
| Jumlah Dagangan | 971,146 |
| Purata Dagangan (3B) | 892,812 |
| Modal Pasaran | 147,738,720 |
| Harga / Buku (P/B) | 1.30 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Nov 2026 |
| EPS Cair (TTM) | -1.49 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.67% |
| Nisbah Semasa (MRQ) | 18.03 |
| Aliran Tunai Operasi (OCF TTM) | -40.14 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -26.32 M |
| Pulangan Atas Aset (ROA TTM) | -27.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -41.88% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Protara Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | 0.76 |
|
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD). |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.61% |
| % Dimiliki oleh Institusi | 76.24% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |